Loading...
Loading...
HLN| Name | Value |
|---|---|
| Revenues | 2,892.0M |
| Cost of Revenue | 1,073.0M |
| Gross Profit | 1,819.0M |
| Operating Expense | 1,250.0M |
| Operating I/L | 569.0M |
| Other Income/Expense | -74.0M |
| Interest Income | 7.0M |
| Pretax | 495.0M |
| Income Tax Expense | 130.0M |
| Net Income/Loss | 345.0M |
Haleon plc is a global consumer healthcare company that specializes in the research, development, manufacture, and sale of a wide range of therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. The company's portfolio includes popular brands such as Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. With a presence in multiple regions, including North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific, Haleon plc generates revenue through the sale of its diverse consumer healthcare products.
